L603-0207 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide

L603-0207 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide
L603-0207 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L603-0207
N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L603-0207

Molecular Formula

C23H19N3O6S (C23 H19 N3 O6 S)

Compound Name

N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide

IUPAC name

N-(3-{5-[(2H-13-benzodioxol-5-yl)methyl]-134-oxadiazol-2-yl}phenyl)-4-methoxybenzene-1-sulfonamide

SMILES

COc(cc1)ccc1S(Nc1cc(-c2nnc(Cc(cc3)cc4c3OCO4)o2)ccc1)(=O)=O

InChI

InChI=1S/C23H19N3O6S/c1-29-18-6-8-19(9-7-18)33(27,28)26-17-4-2-3-16(13-17)23-25-24-22(32-23)12-15-5-10-20-21(11-15)31-14-30-20/h2-11,13,26H,12,14H2,1H3

InChI Key

PUHIZHPSLFTLIT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27464742

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.49

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.244

Distribution Coefficient, logD

4.243

Water Solubility, LogSw

-4.44

Polar Surface Area

95.457

Acid Dissociation Constant (pKa)

10.39

Base Dissociation Constant (pKb)

-2.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

L603-0207 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L603-0207 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L603-0207?
Check Price and Availability of L603-0207, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L603-0207 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L603-0207
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L603-0207
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L603-0207 available by request